Trial intelligence / Profile preview

Heptar vs Liquemine in Hemodialysis

NCT05148377Phase 3Completed

Sponsor
Eurofarma
Start
Aug 2007
Primary completion
Dec 2008
Modality
Biologic
01

Overview

A Phase 3 trial of Heptar in chronic kidney disease (CKD), sponsored by Eurofarma. Started Aug 2007; status: completed.

02

Drugs

Heptar
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT05148377.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05148377.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call